Search

Your search keyword '"Erbella, Federico"' showing total 11 results
Start Over Author "Erbella, Federico"
11 results on '"Erbella, Federico"'

2. Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB

Author

Clerici, Daniela, Galli, Laura, Greco, Raffaella, Lugli, Anna P., Erbella, Federico, Ripa, Marco, Tassan Din, Chiara, Nitti, Rosamaria, Giglio, Fabio, Mastaglio, Sara, Lorentino, Francesca, Xue, Elisabetta, Farina, Francesca, Liberatore, Carmine, Poli, Andrea, Carletti, Silvia, Lupo Stanghellini, Maria T., Carrabba, Matteo G., Assanelli, Andrea A., Ruggeri, Annalisa, Bernardi, Massimo, Corti, Consuelo, Peccatori, Jacopo, Mancini, Nicasio, Scarpellini, Paolo, Ciceri, Fabio, Castagna, Antonella, and Oltolini, Chiara

Published
2023
Full Text
View/download PDF

4. COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome

Author

Lupo-Stanghellini, Maria Teresa, Xue, Elisabetta, Mastaglio, Sara, Oltolini, Chiara, Angelillo, Piera, Messina, Carlo, Piemontese, Simona, Girlanda, Stefania, Farina, Francesca, Lazzari, Lorenzo, Cicalese, Maria Pia, Erbella, Federico, Greco, Raffaella, Locatelli, Massimo, Milani, Raffaella, Peccatori, Jacopo, Corti, Consuelo, Marktel, Sarah, Assanelli, Andrea, and Ciceri, Fabio

Published
2021
Full Text
View/download PDF

5. P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.

Author

Aletti, Federico Mario, primary, Ruggeri, Annalisa, additional, Angelillo, Piera, additional, Mastaglio, Sara, additional, Erbella, Federico, additional, Palumbo, Diego, additional, Calori, Giliola, additional, Carrabba, Matteo G., additional, Querini, Patrizia Rovere, additional, Ciceri, Fabio, additional, Tresoldi, Cristina, additional, Fragasso, Gabriele, additional, Cobelli, Francesco De, additional, Zampini, Matteo, additional, Porta, Matteo Giovanni Della, additional, and Bernardi, Massimo, additional

Published
2023
Full Text
View/download PDF

6. Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients

Author

Destito, Michela, primary, Marzullo, Aldo, additional, Leone, Riccardo, additional, Zaffino, Paolo, additional, Steffanoni, Sara, additional, Erbella, Federico, additional, Calimeri, Francesco, additional, Anzalone, Nicoletta, additional, De Momi, Elena, additional, Ferreri, Andrés J. M., additional, Calimeri, Teresa, additional, and Spadea, Maria Francesca, additional

Published
2023
Full Text
View/download PDF

7. Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB

Author

Clerici, Daniela, primary, Galli, Laura, additional, Greco, Raffaella, additional, Lugli, Anna Paola, additional, Erbella, Federico, additional, Ripa, Marco, additional, Tassan Din, Chiara, additional, Nitti, Rosamaria, additional, Giglio, Fabio, additional, Mastaglio, Sara, additional, Lorentino, Francesca, additional, Xue, Elisabetta, additional, Farina, Francesca, additional, Liberatore, Carmine, additional, POLI, ANDREA, additional, Carletti, Silvia, additional, Lupo Stanghellini, Maria Teresa, additional, Carrabba, Matteo Giovanni Giovanni, additional, Assanelli, Andrea Angelo, additional, Ruggeri, Annalisa, additional, Bernardi, Massimo, additional, Corti, Consuelo, additional, Peccatori, Jacopo, additional, Mancini, Nicasio, additional, Scarpellini, Paolo, additional, Ciceri, Fabio, additional, Castagna, Antonella, additional, and Oltolini, Chiara, additional

Published
2022
Full Text
View/download PDF

8. Ibrutinib Alone or in Combination with R-CHOP Chemoimmunotherapy in Relapsed or Refractory Primary Central Nervous System Lymphoma (rrPCNSL): A «Real-Life» Study

Author

Calimeri, Teresa, primary, Erbella, Federico, additional, Orsucci, Lorella, additional, Aloisi, Teresa, additional, Arcari, Annalisa, additional, Botta, Cirino, additional, Cuccaro, Annarosa, additional, Frascione, Pio Manlio Mirko, additional, Girlanda, Stefania, additional, Gotti, Manuel, additional, Mariani, Sabrina, additional, Nassi, Luca, additional, Ronconi, Fioravante, additional, Schiattone, Luana, additional, Tucci, Alessandra, additional, Verga, Luisa, additional, Mercurio, Vincenzo, additional, Fiore, Paolo, additional, Steffanoni, Sara, additional, Ciceri, Fabio, additional, and Ferreri, Andrés J.M., additional

Published
2022
Full Text
View/download PDF

9. Late Failure of Aggressive B-Cell Lymphoma Following CAR T-Cell Therapy: A Lysa Study from the Descar-T Registry

Author

Erbella, Federico, primary, Bachy, Emmanuel, additional, Cartron, Guillaume, additional, Gat, Elodie, additional, Morschhauser, Franck, additional, Tessoulin, Benoit, additional, Tournilhac, Olivier, additional, Sylvain, Choquet, additional, Gros, François-Xavier, additional, Castilla-Llorente, Cristina, additional, Campidelli, Arnaud, additional, Casasnovas, René-Olivier, additional, Roulin, Louise, additional, Bories, Pierre, additional, Mohty, Mohamad, additional, Carre, Martin, additional, Le Gouill, Steven, additional, Houot, Roch, additional, and Di Blasi, Roberta, additional

Published
2022
Full Text
View/download PDF

10. Radiomics-based machine learning model for predicting Overall and Progression-Free Survival in rare cancer: a case study for Primary CNS Lymphoma patients

Author

Destito, Michela, primary, Marzullo, Aldo, additional, Leone, Riccardo, additional, Zaffino, Paolo, additional, Steffanoni, Sara, additional, Erbella, Federico, additional, Calimeri, Francesco, additional, Anzalone, Nicoletta, additional, De Momi, Elena, additional, Ferreri, Andrés J.M., additional, Calimeri, Teresa, additional, and Spadea, Maria Francesca, additional

Published
2022
Full Text
View/download PDF

11. Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB

Author

Clerici, Daniela, Galli, Laura, Greco, Raffaella, Lugli, Anna P., Erbella, Federico, Ripa, Marco, Din, Chiara Tassan, Nitti, Rosamaria, Giglio, Fabio, Mastaglio, Sara, Lorentino, Francesca, Xue, Elisabetta, Farina, Francesca, Liberatore, Carmine, Poli, Andrea, Carletti, Silvia, Lupo Stanghellini, Maria T., Carrabba, Matteo G., Assanelli, Andrea A., Ruggeri, Annalisa, Bernardi, Massimo, Corti, Consuelo, Peccatori, Jacopo, Mancini, Nicasio, Scarpellini, Paolo, Ciceri, Fabio, Castagna, Antonella, and Oltolini, Chiara

Abstract

Fluoroquinolone prophylaxis’s (FQ-P) usefulness in patients with neutropenia is controversial. In recent decades, Italian epidemiological data has shown worrisome rates of FQ resistance. A single-center cohort study on 136 autologous stem cell transplantations (ASCTs) and 223 allogeneic hematopoietic stem cell transplantations (allo-HSCTs) was performed from January 2018 to December 2020. Piperacillin/tazobactam was the first-line therapy for febrile neutropenia (FN). Since February 2019, FQ-P has been omitted. We evaluated the day +30 posttransplant cumulative incidence function (CIF) of gram-negative bacteria (GNB) pre-engraftment blood-stream infections (PE-BSIs) and any changes in antimicrobial resistance, FN, and infection-related mortality (IRM). In ASCTs, ≥1 FN episode occurred in 74.3% of transplants, without differences among groups (P = .66). CIF of GNB PE-BSI was 10.1%, with a significant difference according to FQ-P (0% [LEVO-group] vs 14.1% [NO-LEVO-group], P = .016). CIF of IRM was 0% in both groups. In allo-HSCTs, ≥1 FN episode occurred in 96.4% of transplants, without differences among groups (P = .72). CIF of GNB PE-BSI was 28%, and it was significantly higher without FQ-P (14.7% [LEVO-group] vs 34.4% [NO-LEVO-group], P = .003). CIF of IRM was 5%, superimposable in both groups (P = .62). Comparing antimicrobial resistance among GNB in the setting of allo-HSCT, in the group without FQ-P, a significantly higher proportion of pathogens was susceptible to piperacillin/tazobactam (71% vs 30%, P = .026), FQ (49% vs 10%, P = .03), and carbapenems (95% vs 50%, P = .001). FQ-P discontinuation increased GNB PE-BSI but did not impact IRM, both in the ASCT and allo-HSCT settings; importantly, it concurred to significantly decrease antimicrobial resistance in GNB.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results